MedTrace Logo

Cardiac Injury in COVID-19: a Pathology Study

NCT04367792 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-08-10

No results posted yet for this study

Summary

The primary goal of the study is to conduct the first systematic cardiac autopsy study in 60 patients dying from COVID-19 to understand the pathology and pathogenesis of cardiac injury in patients with COVID-19, with/without cardiovascular comorbidities. Such data is essential for understanding rate of involvement, type of involvement and degree of injury in patients contracting the disease.

Conditions

Sponsors & Collaborators

  • CVPath Institute Inc. Renu Virmani, Aloke Finn

    collaborator UNKNOWN

  • A.O. Ospedale Papa Giovanni XXIII, Anatomia Patologica, Dr Andrea Gianatti, co-PI

    collaborator UNKNOWN

  • A.O. Ospedale Papa Giovanni XXIII

    lead OTHER

Principal Investigators

  • CTC CLINICAL TRIAL CENTER · Clinical Trials Center - Ospedale Papa Giovanni XXIII Bergamo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2020-10-31
Completion
2021-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367792 on ClinicalTrials.gov